Tower Research Capital LLC (Trc) Adagio Therapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.53 Billion
- Q2 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Adagio Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 15,211 shares of ADGI stock, worth $50,348. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,211
Previous 16,203
6.12%
Holding current value
$50,348
Previous $53,000
5.66%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding ADGI
# of Institutions
67Shares Held
63.7MCall Options Held
13.9KPut Options Held
0-
Mithril Ii Gp LP Austin, TX11.2MShares$37.2 Million27.49% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10.2MShares$33.9 Million0.58% of portfolio
-
M28 Capital Management LP Stamford, CT9.25MShares$30.6 Million39.04% of portfolio
-
Deep Track Capital, LP Greenwich, CT8.59MShares$28.4 Million1.01% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$14.8 Million0.0% of portfolio
About Adagio Therapeutics, Inc.
- Ticker ADGI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 108,831,000
- Market Cap $505M
- Description
- Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatmen...